valneva se glp-1 receptor agonist weight management diabetes treatments Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH November Blog - What happens
Description
A needle-free option, 100% online.
The real problem seems to be retention
Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021
Given that there are now GLP-1 pills, I'm wondering if the adoption curve will change
Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data
